sábado, 11 de abril de 2026
Want muscle from creatine? Resistance training is the missing link
https://www.news-medical.net/news/20260410/Want-muscle-from-creatine-Resistance-training-is-the-missing-link.aspx
A new meta-analysis reveals that while creatine consistently boosts high-intensity performance, its muscle-building potential depends on pairing supplementation with the right type of training.
When recommendations meet reality: the challenge of walking in the Americas The Lancet Regional Health – Americas +++ +...
Early-onset colorectal cancer in Argentina: a multicenter surgical analysis of incidence, stage, and metastatic patterns
Juan Pablo Campanaa ∙ Tomas Cifonea ∙ Esteban Gonzalez Salazara ∙ Gustavo Rossia ∙ Ricardo Mentza ∙ Carlos Vaccaroa ∙ et al.
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(26)00045-1/fulltext?dgcid=raven_jbs_etoc_feature_lanam
Renal cell carcinoma incidence and mortality in California: a population-based study of sociodemographic patterns and temporal trends from 1988 through 2019
Kevin L'Espérancea,b klesp@stanford.edu ∙ Katherine Linc ∙ Daphne Lichtensztajnc ∙ Simon John Christoph Soerensena,b ∙ Shuchi Gulatid ∙ Zhengyi Denga,b ∙ et al.
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(26)00060-8/fulltext?dgcid=raven_jbs_etoc_feature_lanam
When recommendations meet reality: the challenge of walking in the Americas
The Lancet Regional Health – Americas
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(26)00103-1/fulltext?dgcid=raven_jbs_etoc_email
Apr 2026
Volume 56
https://www.thelancet.com/journals/lanam/issue/vol56nonull/PIIS2667-193X(26)X2001-4
Diagnostics and therapeutics: the CRISPR story continues The Lancet Microbe ++... ++
Diagnostics and therapeutics: the CRISPR story continues
The Lancet Microbe
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00072-8/fulltext?dgcid=raven_jbs_etoc_email
Apr 2026
Volume 7Number 4
https://www.thelancet.com/journals/lanmic/issue/vol7no4/PIIS2666-5247(26)X2003-1
Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study
Hans de Graaf, PhDa,b,c,d,∗ ∙ Diane F Gbesemete, PhDa,b,e,∗ ∙ Alison R Hill, PhDa,b,e,∗ ∙ Janeri Fröberg, PhDc,d ∙ Muktar M Ibrahim, PhDe ∙ Adam P Dale, PhDa,b,e ∙ et al.
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00241-1/fulltext?dgcid=raven_jbs_etoc_feature_lanmic
Safety, recovery, and pharmacodynamics of CRISPR–Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study
Anders Østergaard Petersen, PhDa ∙ Birgitte Damholt, PhDa ∙ Mette Grove, PhDa ∙ Jonas Hink, PhDa ∙ Tamara Marotte-Hurbon, MSca ∙ Johan Söderqvist, MSca ∙ et al.
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00185-5/fulltext?dgcid=raven_jbs_etoc_feature_lanmic
Suscribirse a:
Comentarios (Atom)

